Cargando…
The Association of Metformin, Other Antidiabetic Medications and Statins on the Prognosis of Rectal Cancer in Patients with Type 2 Diabetes: A Retrospective Cohort Study
Metformin and statin use have been associated with an improved prognosis for colorectal cancer in persons with type 2 diabetes (T2D). Data regarding rectal cancer (RC) have been inconclusive; therefore, we investigated the issue with high-quality data and a robust study design. We identified 1271 el...
Autores principales: | Erkinantti, Sami, Hautakoski, Ari, Sund, Reijo, Arffman, Martti, Urpilainen, Elina, Puistola, Ulla, Läärä, Esa, Jukkola, Arja, Karihtala, Peeter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496504/ https://www.ncbi.nlm.nih.gov/pubmed/36139140 http://dx.doi.org/10.3390/biom12091301 |
Ejemplares similares
-
The Association of Metformin, Other Antidiabetic Medications, and Statins With the Prognosis of Colon Cancer in Patients With Type 2 Diabetes: A Retrospective Cohort Study
por: Erkinantti, Sami, et al.
Publicado: (2022) -
Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes
por: Hosio, Mayu, et al.
Publicado: (2019) -
Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes
por: Hosio, Mayu, et al.
Publicado: (2021) -
Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
por: Urpilainen, Elina, et al.
Publicado: (2018) -
Metformin and ovarian cancer: the evidence
por: Urpilainen, Elina, et al.
Publicado: (2020)